Global Automated Needle Targeting (ANT) Market Research Report 2024

Publication ID:

PB503245044

Publication Date:

March 12, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

ANT analyzes the X-ray or CT images, generates 2D (X-ray) or 3D (CT) models, and the puncture path was automatically calculated and transformed to motion parameters for the puncture robot through the artificial intelligence (AI) algorithms, thereby assisting doctors with accurate biopsies.
The global Automated Needle Targeting (ANT) market was valued at US$ 2337.4 million in 2023 and is anticipated to reach US$ 3407.7 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Increasing demand for minimally invasive procedures: Minimally invasive procedures offer advantages such as shorter hospital stays, faster recovery times, and reduced complications. ANT systems enable healthcare providers to perform these procedures with greater precision, making them more attractive to both patients and healthcare professionals.
Technological advancements: ANT systems continue to benefit from advancements in imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). These technologies provide real-time, high-resolution imaging, allowing for more accurate needle targeting and placement.
Rising prevalence of chronic diseases: The growing prevalence of chronic diseases like cancer and cardiovascular disorders has led to an increased demand for diagnostic and therapeutic procedures. ANT systems can aid in the precise targeting of tumors, lesions, and other affected areas, improving the effectiveness of treatments.
Improved patient outcomes: The use of ANT systems can reduce the risk of complications associated with needle-based procedures, such as organ damage or bleeding. By improving accuracy and reducing errors, these systems contribute to better patient outcomes and overall satisfaction.
This report aims to provide a comprehensive presentation of the global market for Automated Needle Targeting (ANT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Needle Targeting (ANT).
Report Scope
The Automated Needle Targeting (ANT) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Needle Targeting (ANT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Needle Targeting (ANT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NDR Medical
Microport
Zimmer Biomet
Smith & Nephew
Cgbio Inc.
Fraunhofer IPA
Segment by Type
Percutaneous Lung Biopsy
Percutaneous Nephrolithotomy
Segment by Application
Hospitals
Ambulatory Surgical Center
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Needle Targeting (ANT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Needle Targeting (ANT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Automated Needle Targeting (ANT) Market Overview
1.1 Product Overview and Scope of Automated Needle Targeting (ANT)
1.2 Automated Needle Targeting (ANT) Segment by Type
1.2.1 Global Automated Needle Targeting (ANT) Market Value Comparison by Type (2024-2030)
1.2.2 Percutaneous Lung Biopsy
1.2.3 Percutaneous Nephrolithotomy
1.3 Automated Needle Targeting (ANT) Segment by Application
1.3.1 Global Automated Needle Targeting (ANT) Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Global Automated Needle Targeting (ANT) Market Size Estimates and Forecasts
1.4.1 Global Automated Needle Targeting (ANT) Revenue 2019-2030
1.4.2 Global Automated Needle Targeting (ANT) Sales 2019-2030
1.4.3 Global Automated Needle Targeting (ANT) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automated Needle Targeting (ANT) Market Competition by Manufacturers
2.1 Global Automated Needle Targeting (ANT) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automated Needle Targeting (ANT) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automated Needle Targeting (ANT) Average Price by Manufacturers (2019-2024)
2.4 Global Automated Needle Targeting (ANT) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automated Needle Targeting (ANT), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Needle Targeting (ANT), Product Type & Application
2.7 Automated Needle Targeting (ANT) Market Competitive Situation and Trends
2.7.1 Automated Needle Targeting (ANT) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Needle Targeting (ANT) Players Market Share by Revenue
2.7.3 Global Automated Needle Targeting (ANT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Needle Targeting (ANT) Retrospective Market Scenario by Region
3.1 Global Automated Needle Targeting (ANT) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automated Needle Targeting (ANT) Global Automated Needle Targeting (ANT) Sales by Region: 2019-2030
3.2.1 Global Automated Needle Targeting (ANT) Sales by Region: 2019-2024
3.2.2 Global Automated Needle Targeting (ANT) Sales by Region: 2025-2030
3.3 Global Automated Needle Targeting (ANT) Global Automated Needle Targeting (ANT) Revenue by Region: 2019-2030
3.3.1 Global Automated Needle Targeting (ANT) Revenue by Region: 2019-2024
3.3.2 Global Automated Needle Targeting (ANT) Revenue by Region: 2025-2030
3.4 North America Automated Needle Targeting (ANT) Market Facts & Figures by Country
3.4.1 North America Automated Needle Targeting (ANT) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automated Needle Targeting (ANT) Sales by Country (2019-2030)
3.4.3 North America Automated Needle Targeting (ANT) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automated Needle Targeting (ANT) Market Facts & Figures by Country
3.5.1 Europe Automated Needle Targeting (ANT) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automated Needle Targeting (ANT) Sales by Country (2019-2030)
3.5.3 Europe Automated Needle Targeting (ANT) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Needle Targeting (ANT) Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Needle Targeting (ANT) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automated Needle Targeting (ANT) Sales by Country (2019-2030)
3.6.3 Asia Pacific Automated Needle Targeting (ANT) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Automated Needle Targeting (ANT) Market Facts & Figures by Country
3.7.1 Latin America Automated Needle Targeting (ANT) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automated Needle Targeting (ANT) Sales by Country (2019-2030)
3.7.3 Latin America Automated Needle Targeting (ANT) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Needle Targeting (ANT) Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Needle Targeting (ANT) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automated Needle Targeting (ANT) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automated Needle Targeting (ANT) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Needle Targeting (ANT) Sales by Type (2019-2030)
4.1.1 Global Automated Needle Targeting (ANT) Sales by Type (2019-2024)
4.1.2 Global Automated Needle Targeting (ANT) Sales by Type (2025-2030)
4.1.3 Global Automated Needle Targeting (ANT) Sales Market Share by Type (2019-2030)
4.2 Global Automated Needle Targeting (ANT) Revenue by Type (2019-2030)
4.2.1 Global Automated Needle Targeting (ANT) Revenue by Type (2019-2024)
4.2.2 Global Automated Needle Targeting (ANT) Revenue by Type (2025-2030)
4.2.3 Global Automated Needle Targeting (ANT) Revenue Market Share by Type (2019-2030)
4.3 Global Automated Needle Targeting (ANT) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automated Needle Targeting (ANT) Sales by Application (2019-2030)
5.1.1 Global Automated Needle Targeting (ANT) Sales by Application (2019-2024)
5.1.2 Global Automated Needle Targeting (ANT) Sales by Application (2025-2030)
5.1.3 Global Automated Needle Targeting (ANT) Sales Market Share by Application (2019-2030)
5.2 Global Automated Needle Targeting (ANT) Revenue by Application (2019-2030)
5.2.1 Global Automated Needle Targeting (ANT) Revenue by Application (2019-2024)
5.2.2 Global Automated Needle Targeting (ANT) Revenue by Application (2025-2030)
5.2.3 Global Automated Needle Targeting (ANT) Revenue Market Share by Application (2019-2030)
5.3 Global Automated Needle Targeting (ANT) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 NDR Medical
6.1.1 NDR Medical Corporation Information
6.1.2 NDR Medical Description and Business Overview
6.1.3 NDR Medical Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 NDR Medical Automated Needle Targeting (ANT) Product Portfolio
6.1.5 NDR Medical Recent Developments/Updates
6.2 Microport
6.2.1 Microport Corporation Information
6.2.2 Microport Description and Business Overview
6.2.3 Microport Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Microport Automated Needle Targeting (ANT) Product Portfolio
6.2.5 Microport Recent Developments/Updates
6.3 Zimmer Biomet
6.3.1 Zimmer Biomet Corporation Information
6.3.2 Zimmer Biomet Description and Business Overview
6.3.3 Zimmer Biomet Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zimmer Biomet Automated Needle Targeting (ANT) Product Portfolio
6.3.5 Zimmer Biomet Recent Developments/Updates
6.4 Smith & Nephew
6.4.1 Smith & Nephew Corporation Information
6.4.2 Smith & Nephew Description and Business Overview
6.4.3 Smith & Nephew Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Smith & Nephew Automated Needle Targeting (ANT) Product Portfolio
6.4.5 Smith & Nephew Recent Developments/Updates
6.5 Cgbio Inc.
6.5.1 Cgbio Inc. Corporation Information
6.5.2 Cgbio Inc. Description and Business Overview
6.5.3 Cgbio Inc. Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cgbio Inc. Automated Needle Targeting (ANT) Product Portfolio
6.5.5 Cgbio Inc. Recent Developments/Updates
6.6 Fraunhofer IPA
6.6.1 Fraunhofer IPA Corporation Information
6.6.2 Fraunhofer IPA Description and Business Overview
6.6.3 Fraunhofer IPA Automated Needle Targeting (ANT) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fraunhofer IPA Automated Needle Targeting (ANT) Product Portfolio
6.6.5 Fraunhofer IPA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Needle Targeting (ANT) Industry Chain Analysis
7.2 Automated Needle Targeting (ANT) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Needle Targeting (ANT) Production Mode & Process
7.4 Automated Needle Targeting (ANT) Sales and Marketing
7.4.1 Automated Needle Targeting (ANT) Sales Channels
7.4.2 Automated Needle Targeting (ANT) Distributors
7.5 Automated Needle Targeting (ANT) Customers
8 Automated Needle Targeting (ANT) Market Dynamics
8.1 Automated Needle Targeting (ANT) Industry Trends
8.2 Automated Needle Targeting (ANT) Market Drivers
8.3 Automated Needle Targeting (ANT) Market Challenges
8.4 Automated Needle Targeting (ANT) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

NDR Medical
Microport
Zimmer Biomet
Smith & Nephew
Cgbio Inc.
Fraunhofer IPA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂